Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at AACR Annual Meeting|Apr. 5-10, 2024|Booth #2953

Recombinant Mouse ARHGEF7 Protein

Cat.No. : ARHGEF7-1907M
Product Overview : Recombinant Mouse ARHGEF7 full length or partial length protein was expressed.
  • Specification
  • Gene Information
  • Related Products
Source : Mammalian Cells
Species : Mouse
Tag : His
Form : Liquid or lyophilized powder
Endotoxin : < 1.0 EU per μg of the protein as determined by the LAL method.
Purity : >80%
Notes : This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.
Storage : Store it at +4 ºC for short term. For long term storage, store it at -20 ºC~-80 ºC.
Storage Buffer : PBS buffer
Gene Name : Arhgef7 Rho guanine nucleotide exchange factor (GEF7) [ Mus musculus ]
Official Symbol : ARHGEF7
Gene ID : 54126
mRNA Refseq : NM_001113517.1
Protein Refseq : NP_001106989.1
MIM :
UniProt ID : Q9ES28

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Inquiry

  • Q&As
  • Reviews

Q&As (18)

Ask a question
What are the cellular processes or pathways regulated by ARHGEF7 in addition to Rho GTPase activation? 03/22/2023

In addition to Rho GTPase activation, ARHGEF7 regulates various cellular processes and pathways. It can modulate actin dynamics and actomyosin contractility, leading to changes in cell shape and motility. ARHGEF7 also contributes to the regulation of cell adhesion and cell-matrix interactions by influencing focal adhesion turnover and integrin signaling. Furthermore, ARHGEF7 has been reported to interact with and modulate the activity of other signaling molecules, such as kinases and phosphatases, suggesting its involvement in diverse signaling pathways within the cell.

Are there any known pharmacological agents that can modulate ARHGEF7 expression or activity? 02/26/2023

Currently, there are no pharmacological agents specifically designed to modulate ARHGEF7 expression or activity. However, certain drugs or therapeutic approaches that target upstream signaling pathways and regulators of ARHGEF7, such as growth factor receptor inhibitors or kinase inhibitors, may indirectly affect ARHGEF7 activity. Manipulating ARHGEF7 expression or activity using gene therapy or RNA interference techniques may also hold potential for therapeutic intervention, but further research is required in this area.

What are the downstream signaling pathways activated by ARHGEF7? 04/27/2022

ARHGEF7 activates downstream signaling pathways primarily through its interaction with and activation of Rho GTPases, particularly RAC1. Activation of RAC1 by ARHGEF7 leads to the activation of various effector proteins, including p21-activated kinase (PAK), to regulate cytoskeletal dynamics, cell migration, and other cellular processes. ARHGEF7-mediated RhoA activation can also contribute to downstream signaling events related to actomyosin contractility and cell adhesion.

Are there any genetic mutations or alterations in ARHGEF7 associated with disease? 09/12/2021

Yes, there have been studies reporting genetic mutations or alterations in ARHGEF7 that are associated with certain diseases. For example, mutations in ARHGEF7 have been found in individuals with X-linked intellectual disability (XLID) and epilepsy, suggesting a role for ARHGEF7 in neurological development and function. Additionally, alterations in ARHGEF7 expression have been observed in various cancers, including breast, lung, and pancreatic cancer, and have been linked to tumor progression and metastasis.

Are there any known interacting proteins of ARHGEF7? 08/17/2021

ARHGEF7 interacts with multiple proteins to carry out its functions. It interacts with RAC1, PAK1, and other components of the cytoskeleton, such as actin and microtubules. ARHGEF7 can also interact with various signaling molecules and adaptor proteins, allowing it to integrate and transduce signals from multiple cellular pathways.

Can genetic variations in ARHGEF7 contribute to disease susceptibility? 06/24/2021

There is accumulating evidence that genetic variations in ARHGEF7 can contribute to disease susceptibility. Single nucleotide polymorphisms (SNPs) and structural variations in the ARHGEF7 gene have been associated with conditions such as cancer, neurodevelopmental disorders, and neurodegenerative diseases, suggesting a potential role of ARHGEF7 in disease pathogenesis.

Are there any known small molecule inhibitors of ARHGEF7? 11/05/2020

Currently, there are no specific small molecule inhibitors available for ARHGEF7. However, inhibitors targeting the downstream effectors or regulators of ARHGEF7, such as inhibitors of Rho GTPases or ROCK, may indirectly impact ARHGEF7-mediated signaling. Developing specific small molecule inhibitors for ARHGEF7 remains an active area of research.

Does ARHGEF7 play a role in cell adhesion and migration? 08/29/2020

Yes, ARHGEF7 is involved in cell adhesion and migration processes. It promotes the formation of focal adhesions and actin stress fibers, which are essential for cell attachment and migration. ARHGEF7-mediated activation of RAC1 regulates important cytoskeletal rearrangements necessary for cell motility, including the formation of lamellipodia and filopodia.

Are there any therapeutic strategies targeting ARHGEF7? 06/23/2019

While there are no specific therapeutics targeting ARHGEF7 currently available, its downstream target RAC1 has been a focus of drug development. Inhibitors of RAC1 signaling are being explored as potential anti-cancer agents. Modulating the activity or expression of ARHGEF7 itself may also hold therapeutic potential, but more research is needed to understand its precise role in disease pathogenesis and identify effective targeting strategies.

Are there any diseases associated with ARHGEF7 dysfunction? 12/07/2018

Dysregulation of ARHGEF7 has been implicated in various diseases. For example, ARHGEF7 is involved in cancer progression, where its overexpression can promote tumor cell migration and metastasis. ARHGEF7 variants or mutations have also been associated with neurodevelopmental disorders such as autism spectrum disorder (ASD) and intellectual disabilities.

Does ARHGEF7 have any known alternative splicing isoforms? 11/08/2018

Yes, ARHGEF7 can undergo alternative splicing, resulting in the generation of different isoforms. These isoforms may have distinct functions or subcellular localizations, contributing to the functional diversity of ARHGEF7. Further research is needed to fully understand the individual roles of these isoforms and their significance in different cellular contexts.

How does ARHGEF7 activate RAC1? 09/28/2018

ARHGEF7 interacts with RAC1 and catalyzes the exchange of GDP for GTP on RAC1. This activates RAC1 by promoting its transition from the inactive GDP-bound form to the active GTP-bound form. Activated RAC1 then regulates downstream signaling pathways involved in cytoskeletal rearrangement and cell behavior.

Can ARHGEF7 be involved in neuronal development and function? 09/16/2018

Yes, ARHGEF7 plays a role in neuronal development and synaptic plasticity. It is expressed in the brain and has been implicated in dendritic spine morphogenesis and synapse formation. ARHGEF7 interacts with PAK1, a kinase important for synaptic plasticity, suggesting its involvement in neuronal signaling and connectivity.

Are there any other functions or roles of ARHGEF7 besides its involvement in cell migration and cytoskeletal dynamics? 06/17/2018

Yes, ARHGEF7 has other functions and roles beyond cell migration and cytoskeletal dynamics. It has been implicated in the regulation of cell polarity, epithelial-mesenchymal transition (EMT), and cell adhesion. ARHGEF7 has also been shown to be involved in the regulation of cell proliferation, cell survival, and angiogenesis. Furthermore, studies have suggested a potential role for ARHGEF7 in neuronal development and synaptic plasticity in the brain.

Does ARHGEF7 have any roles in cancer progression or metastasis? 07/24/2017

Yes, ARHGEF7 has been implicated in cancer progression and metastasis. It is known to promote tumor cell invasion and migration by enhancing cytoskeletal dynamics and modulating cell-matrix adhesion. Increased expression of ARHGEF7 has been associated with poor prognosis in various cancer types, suggesting its potential as a therapeutic target. However, further research is needed to fully elucidate the specific mechanisms and roles of ARHGEF7 in cancer progression.

Are there any known regulators or inhibitors of ARHGEF7 activity? 10/14/2016

Yes, several regulators and inhibitors of ARHGEF7 activity have been identified. One example is the Rho GTPase-activating protein (RhoGAP) ARHGAP25, which can bind and inhibit ARHGEF7, thereby negatively regulating its activity. Additionally, certain proteins or signaling pathways, such as Rho kinase (ROCK) and protein kinase C (PKC), can modulate ARHGEF7 activity through phosphorylation or other post-translational modifications.

Is there an animal model available to study ARHGEF7 function? 06/20/2016

Yes, mouse models with targeted disruption or mutations in the Arhgef7 gene have been generated. These models have been utilized to investigate the role of ARHGEF7 in various physiological processes, including neuronal development, neural circuit formation, and disease-related phenotypes.

Can ARHGEF7 interact with other members of the Rho GTPase family? 04/04/2016

Yes, besides its well-known interaction with RAC1, ARHGEF7 can also interact with other members of the Rho GTPase family, such as RhoA and CDC42. These interactions enable ARHGEF7 to regulate the activity and signaling of multiple Rho GTPases, allowing for a coordinated control of cytoskeletal dynamics and cell behaviors.

Customer Reviews (8)

Write a review
Reviews
04/30/2022

    With the ARHGEF7 protein as a research tool, achieving meaningful scientific findings becomes an accessible and achievable goal.

    12/20/2021

      The ARHGEF7 protein is a superior-quality protein that perfectly aligns with my experimental requirements.

      10/17/2020

        ARHGEF7 protein is highly recommended for researchers and scientists due to its exceptional performance in ELISA assays.

        10/01/2019

          ARHGEF7 protein has proven to be instrumental in protein electron microscopy structure analysis.

          09/17/2018

            the ARHGEF7 protein's versatility extends beyond its use in vitro experiments.

            08/19/2018

              Its stability and well-defined structure make it an excellent candidate for visualizing and understanding the three-dimensional arrangement of proteins at a high resolution.

              12/11/2017

                Whether investigating the role of ARHGEF7 in angiogenesis, vascular development, or disease pathways, this protein surpasses expectations and guarantees reliable results.

                06/26/2016

                  Its superior binding affinity and specificity enable accurate and reliable detection of target analytes in various biological samples.

                  Ask a Question for All ARHGEF7 Products

                  Required fields are marked with *

                  My Review for All ARHGEF7 Products

                  Required fields are marked with *

                  0

                  Inquiry Basket

                  cartIcon
                  logo

                  FOLLOW US

                  Terms and Conditions        Privacy Policy

                  Copyright © 2024 Creative BioMart. All Rights Reserved.

                  Contact Us

                  • /

                  Stay Updated on the Latest Bioscience Trends